These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6271727)

  • 41. Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins.
    White RL; Kays MB; Friedrich LV; Del Bene VE
    J Antimicrob Chemother; 1993 Jan; 31(1):57-64. PubMed ID: 8444675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporins.
    Jones RN; Wilson HW
    Infection; 1982; 10(5):303-6. PubMed ID: 6293977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-vitro and in-vivo activities of a novel cephamycin MT-141 against the Bacteroides fragilis group in comparison with six cephem antibiotics.
    Kasai T; Hara T; Tamura A; Kazuno Y; Inouye S; Goto S; Kuwahara S
    J Antimicrob Chemother; 1985 Jun; 15(6):701-14. PubMed ID: 3928575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
    Prère MF; Lefèvre JC; Lareng MB
    Chemotherapy; 1981; 27 Suppl 1():15-8. PubMed ID: 6265158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
    Andrew JH; Greenwood D
    J Antimicrob Chemother; 1987 May; 19(5):591-5. PubMed ID: 3497146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis.
    Cuchural GJ; Tally FP; Storey JR; Malamy MH
    Antimicrob Agents Chemother; 1986 May; 29(5):918-20. PubMed ID: 3488018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
    Neu HC; Chin NX; Labthavikul P
    Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 May; 17(5):901-4. PubMed ID: 6249198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The in vitro responses of Bacteroides fragilis to Moxalactam, Cefotaxime, Cefmetazole, Josamycin and erythromycin.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1166-7. PubMed ID: 6290543
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH; Nelson JD; Grimm L
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
    Del Bene VE; Carek PJ; Twitty JA; Burkey LJ
    Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.
    Eley A; Greenwood D
    Antimicrob Agents Chemother; 1981 Sep; 20(3):332-5. PubMed ID: 6272629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Neu HC
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract]   [Full Text] [Related]  

  • 56. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
    Dornbusch K; Adamsson L; Gezelius L; Hallander H
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
    Jones RN; Barry AL; Aldridge KE; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
    Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
    Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
    Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():99-104. PubMed ID: 6296035
    [No Abstract]   [Full Text] [Related]  

  • 60. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
    Malouin F; Lamothe F
    Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.